Uluru Inc. (ULUR)
| Market Cap | 16.46M |
| Revenue (ttm) | 568,744 |
| Net Income (ttm) | -2.20M |
| Shares Out | 20.13M |
| EPS (ttm) | -0.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 18 |
| Last Price | $0.5200 |
| Previous Close | $0.5200 |
| Change ($) | 0.0000 |
| Change (%) | 0.00% |
| Day's Open | 0.5200 |
| Day's Range | 0.5200 - 0.5200 |
| Day's Volume | 0 |
| 52-Week Range | 0.1400 - 0.7900 |
News
There are no news available yet.
About ULUR
ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include ... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| Stock Exchange OTCMKTS | Ticker Symbol ULUR |
Financial Performance
In 2017, Uluru Inc.'s revenue was $717,157, an increase of 62.05% compared to the previous year's $442,565. Losses were -$1.94 million, -56.52% less than in 2016.